Suppr超能文献

大体积脑膜瘤及毗邻视神经通路和脑干的脑膜瘤的分次立体定向伽玛刀放射外科治疗的有效性和安全性:初步治疗结果

Effectiveness and safety of hypofractionated gamma knife radiosurgery for large meningiomas and those adjacent to the optic pathway and brainstem: preliminary therapeutic outcomes.

作者信息

Hirano Yudai, Shinya Yuki, Umekawa Motoyuki, Hasegawa Hirotaka, Kawashima Mariko, Wipplinger Christoph, Wipplinger Tamara, Katano Atsuto, Saito Nobuhito

机构信息

Department of Neurosurgery, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.

Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, 55901, USA.

出版信息

Neurosurg Rev. 2025 Jan 15;48(1):49. doi: 10.1007/s10143-025-03199-5.

Abstract

Recent technologic advancements have facilitated the use of hypofractionated Gamma Knife-based radiosurgery (HF-GKRS) to treat large lesions or those in eloquent areas. This study aimed to analyze the preliminary results of HF-GKRS for these meningiomas, and to determine its effectiveness and safety. This single-center retrospective study analyzed data of patients who underwent HF-GKRS for large meningiomas or those in eloquent areas with > 6 months of follow-up. The primary outcome was progression-free survival (PFS). The secondary outcomes were neurological deterioration, post-treatment T2 signal changes following HF-GKRS, and tumor volume changes. Volumetric analysis of the tumors after treatment was also performed to assess changes in tumor size after HF-GKRS. Overall, 24 patients with a median follow-up period of 22 months (range: 6-49 months) were included. Among them, 18 (75%) patients had tumors in close proximity to the optic pathway, and 15 (63%) patients had large lesions (> 10 cm). The cumulative 1- and 3-year PFS rates were 100% and 92%, respectively. The cumulative 3-year rate of adverse radiation effects was 9%. Overall, 12 patients (50%) showed tumor reduction, with a median tumor reduction rate of 45% (range: 25-58%). Our preliminary results revealed that HF-GKRS for large meningiomas or those in eloquent areas is safe and effective, with satisfactory short- and mid-term PFS and low adverse radiation effects. Further research with more patients and longer follow-up periods is required.

摘要

最近的技术进步促进了基于伽玛刀的大分割放射外科手术(HF-GKRS)在治疗大病变或位于功能区的病变中的应用。本研究旨在分析HF-GKRS治疗这些脑膜瘤的初步结果,并确定其有效性和安全性。这项单中心回顾性研究分析了接受HF-GKRS治疗大脑膜瘤或位于功能区且随访时间超过6个月的患者的数据。主要结局是无进展生存期(PFS)。次要结局包括神经功能恶化、HF-GKRS治疗后T2信号变化以及肿瘤体积变化。还对治疗后的肿瘤进行了体积分析,以评估HF-GKRS后肿瘤大小的变化。总体而言,纳入了24例患者,中位随访期为22个月(范围:6 - 49个月)。其中,18例(75%)患者的肿瘤紧邻视路,15例(63%)患者有大病变(>10 cm)。1年和3年的累积PFS率分别为100%和92%。累积3年的不良放射效应发生率为9%。总体而言,12例患者(50%)肿瘤缩小,中位肿瘤缩小率为45%(范围:25% - 58%)。我们的初步结果显示,HF-GKRS治疗大脑膜瘤或位于功能区的脑膜瘤是安全有效的,短期和中期PFS令人满意,不良放射效应较低。需要对更多患者进行更长随访期的进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验